<DOC>
	<DOCNO>NCT02216071</DOCNO>
	<brief_summary>The purpose study demonstrate clinical therapeutic non-inferiority EXL CDOS commercially available Ciprofloxacin 0.3 % Dexamethasone 0.1 % Sterile Otic Suspension ( Ciprodex® , Alcon ) treatment acute otitis externa ( AOE ) administer twice daily 7 day .</brief_summary>
	<brief_title>Comparative Efficacy Safety Two Ciprofloxacin 0.3 % Dexamethasone 0.1 % Formulations Subjects With Acute Otitis Externa</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Male female , 6 month age ; 2 . Clinically documented AOE consistent diagnostic guideline American Academy OtolaryngologyHead Neck Surgery Foundation 1 ear ; 3 . Inflammation and/or edema ≥2 AOE scale , otorrhea and/or tenderness present ; 4 . AOE &lt; 4 week duration ; 5 . Intact tympanic membrane ( ) treat ear ( ) ; 6 . Willingness refrain swim TOC/ Visit 5 ; 7 . For subject AOE associate hear aid use , willingness discontinue use hearing aid ( ) affect ear ( ) TOC/Visit 5 ; 8 . Ability complete study compliance protocol ; 9 . For adult subject , ability understand provide write informed consent ; 10 . For pediatric subject , parent legal guardian provide write informed consent ; 11 . For child age 6 , ability understand provide assent accord institutional requirement . 1 . Acute chronic suppurative otitis medium ; 2 . Posttympanostomy tube acute otorrhea ; 3 . Malignant otitis externa ; 4 . Suspected overt fungal viral ear infection ; 5 . Congenital abnormality obstructive bony exostosis external auditory canal treat ear ( ) ; 6 . Seborrheic dermatitis dermatologic condition external auditory canal treat ear ( ) could confound evaluation ; 7 . Mastoiditis suppurative infectious noninfectious disorder treat ear ( ) ; 8 . Malignant tumor external auditory canal treat ear ( ) ; 9 . History otologic surgery treat ear ( ) , exception tympanic membrane surgery &gt; 6 month prior Baseline ; 10 . Four episode otitis externa ( OE ) previous year ; 11 . Uncontrolled diabetes mellitus ; 12 . Immunosuppressive disorder , include know Human Immunodeficiency Virus infection ; 13 . Renal insufficiency ; 14 . Hepatitis hepatic insufficiency ; 15 . Receipt systemic antibiotic concurrently within 72 hour prior Baseline ; 16 . Receipt topical otic antibiotic within 24 hour prior Baseline ; 17 . Use systemic corticosteroid concurrently within 30 day prior Baseline ; 18 . Use topical otic corticosteroid concurrently within 7 day prior Baseline ; 19 . Concurrent use systemic topical otic nonsteroidal antiinflammatory drug ; 20 . Use topical vinegar , alcohol , astringent otic preparation concurrently within 24 hour prior Baseline ; 21 . Pregnancy , plan pregnancy , lactation ; 22 . Known sensitivity intolerance quinolone antibacterial agent ; 23 . Previous participation trial ; 24 . Participation another investigational drug vaccine trial concurrently within 30 day ; 25 . Significant acute chronic medical , neurologic , psychiatric illness subject parent/guardian , judgment Principal Investigator , could compromise subject safety , limit subject 's ability complete study , and/or compromise objective study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>